April 2026 International Monthly Webinar
Login to Watch this Webinar
To watch the live webinar, login to your account or register to gain access to our exclusive content.
Each month, NCODA’s International Monthly Webinar highlights timely topics, shared learning, and perspectives from across oncology care.
This month, we’re covering policy updates, oncology distribution, new clinical findings from the NAPOLI 3 trial, and strategies to navigate prior authorization and step edits that impact patient access to therapy
This Month’s Lineup:
Opening remarks from Jennifer Berni, CPhT (Stockton Hematology Oncology)
Evaluating the Impact of OOLD on Access to Oral Oncology Therapies – Chris Lehmer, PharmD, MBA (City of Hope), takes a look at how oncology optimized limited distribution (OOLD) models are influencing access to oral therapies, and what that means for care coordination and patient outcomes in integrated oncology pharmacy.
April Legislative & Pharmacy Updates – Douglas Braun, PharmD, CSP (NCODA), walks through the latest federal and state legislative and regulatory changes shaping pharmacy practice in 2026, including implications for reimbursement, patient access, licensure reform, prescriptive authority, PBM oversight, and technician roles.
The Effects of Dose Adjustments on Overall Survival in Patients Treated with NALIRIFOX in the NAPOLI 3 Trial – Lauren Trisler, PharmD, BCOP (Florida Cancer Specialists & Research Institute), reviews the NAPOLI 3 trial and explores how dose adjustments with NALIRIFOX may impact overall survival, including post hoc findings, recommended dose modifications, and key clinical considerations.
Navigating Prior Authorization and Step Edit Challenges in Oncology Care – Kathy Oubre, MS (Pontchartrain Cancer Center), breaks down how prior authorization and step edit requirements affect access to oncology therapies, along with the clinical, operational, and financial implications, and strategies to help reduce delays and improve access.
For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.
